0001493152-22-019853.txt : 20220719 0001493152-22-019853.hdr.sgml : 20220719 20220719170159 ACCESSION NUMBER: 0001493152-22-019853 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220719 DATE AS OF CHANGE: 20220719 EFFECTIVENESS DATE: 20220719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001537561 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 460524102 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-452969 FILM NUMBER: 221092104 BUSINESS ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 BUSINESS PHONE: 617-431-2313 MAIL ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 FORMER COMPANY: FORMER CONFORMED NAME: ALMAH,INC DATE OF NAME CHANGE: 20111216 D 1 primary_doc.xml X0708 D LIVE 0001537561 Arch Therapeutics, Inc. 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA MASSACHUSETTS 01702 617-431-2313 NEVADA Almah, Inc. ALMAH,INC Corporation true Terrence W. Norchi 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Executive Officer Director Punit Dhillon 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Director Laurence Hicks 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Director Guy Fish 236 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Director Michael S. Abrams 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Executive Officer Daniel M. Yrigoyen 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Executive Officer Biotechnology Decline to Disclose 06b false 2022-07-06 false true true false 0 Maxim Group LLP 120708 None None 300 PARK AVE, 16TH FLOOR NEW YORK NY NEW YORK 10022 All States false 4230000 4230000 0 false 16 240000 true 0 Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3. Additionally, warrants were issued to the placement agent at an exercise price of $0.0503 per share. 0 true false Arch Therapeutics, Inc. /s/ Michael S. Abrams Michael S. Abrams Chief Financial Officer 2022-07-19